Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms
Year: 2023
Type: review
Abstract: Ketamine is an open channel blocker of ionotropic glutamatergic N-Methyl-D-Aspartate (NMDA) receptors. The discovery of its rapid antidepressant effects in patients with depression and treatment-resistant depression fostered novel effective treatments for mood disorders. This discovery not only provided new insight into the neurobiology of mood disorders but also uncovered fundamental synaptic plasticity mechanisms that underlie its treatment. In this review, we discuss key clinical aspects of ketamine's effect as a rapidly acting antidepressant, synaptic and circuit mechanisms underlying its action, as well as how these novel perspectives in clinical practice and synapse biology form a road map for future studies aimed at more effective treatments for neuropsychiatric disorders.
Source: Neuropsychopharmacology
Institutions: Yale University, Vanderbilt University
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,790
Funders: U.S. Department of Health and Human Services, U.S. Department of Veterans Affairs, AstraZeneca, Yale University, Biogen, Novartis Pharmaceuticals Corporation, Otsuka America Pharmaceutical, Sunovion, Jazz Pharmaceuticals, Neurocrine Biosciences, Otsuka America, Eisai, National Institutes of Health, Yale School of Medicine, Office of Academic Affiliations, Department of Veterans Affairs, National Center for PTSD, U.S. Department of Veterans Affairs, National Institute on Alcohol Abuse and Alcoholism, National Institute of Mental Health, National Center for Advancing Translational Sciences, Yale Center for Clinical Investigation, Yale School of Medicine
Awards: G1295328191, MECP2 DEPENDENT TRANSCRIPTIONAL REPRESSION & NEUROTRANSMISSION, G3483107903, G3615640089, G3930743029, Role of SNARE Interactions in Central Synapse Function, G6288285971, G7043401965, G8815411394, Center for the Translational Neuroscience of Alcoholism, Antidepressants and Intracellular Signaling Linked to BDNF, Yale Clinical and Translational Science Award
OpenAlex ID: W4385196900
